Eric F. Franssen - Publications

Deprescribing opportunities for patients with advanced non-small cell lung cancer: an observational study of potentially inappropriate medications and stakeholders' perspectives.

Journal: International journal of clinical pharmacy

Published: January 20, 2026

Predictors for Unsuccessful Outcome of Lumbar Spinal Stenosis Surgery: A Secondary Analysis of the Two Randomized NORDSTEN Trials.

Journal: Spine

Published: December 17, 2025

Predictors for Unsuccessful Outcome of Lumbar Spinal Stenosis Surgery: A Secondary Analysis of the 2 Randomized NORDSTEN Trials.

Journal: Spine

Published: December 17, 2025

Acute cardiovascular complaints after recreational drug use

Journal: Nederlands tijdschrift voor geneeskunde

Published: November 19, 2025

Agreement of CT versus MRI in reinvestigation of patients operated for lumbar spinal stenosis. a comparison of surgically and non-surgically treated levels.

Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

Published: November 14, 2025

Twenty Years of Evolution in Toxicology Laboratories: Lessons Learned to Face Upcoming Challenges in Health Care and Society.

Journal: Therapeutic drug monitoring

Published: November 13, 2025

Added value of post-mortem toxicological blood testing in medicolegal death investigations in Amsterdam and surrounding regions, 2017-2018.

Journal: Human & experimental toxicology

Published: October 22, 2025

Early-onset hematological toxicity of docetaxel and survival in non-small cell lung cancer patients in the immune checkpoint inhibition era.

Journal: Cancer treatment and research communications

Published: September 01, 2025

Urine Drug Testing: Service Models and Laboratory Practices to Meet Clinical Care Needs.

Journal: Therapeutic drug monitoring

Published: July 31, 2025

TDM-Based Tailored Dosing of Durvalumab in Lung Cancer Patients: A Comprehensive Population Pharmacokinetic-Pharmacoeconomic Evaluation.

Journal: Clinical pharmacokinetics

Published: July 14, 2025

Early pembrolizumab clearance as prognostic biomarker for non-response in patients with advanced non-small cell lung cancer.

Journal: International journal of cancer

Published: April 24, 2025

Comparative evaluation of the ability to detect major cardiac events with the modified cocaine history, electrocardiogram, age, risk factors and troponin (HEART) score, HEART pathway and original HEART score in patients with cocaine-associated chest pain presenting at the emergency department.

Journal: Clinical toxicology (Philadelphia, Pa.)

Published: April 14, 2025